\documentclass[10pt]{article}

\usepackage{fullpage}
\usepackage{setspace}
\usepackage{parskip}
\usepackage{titlesec}
\usepackage[section]{placeins}
\usepackage{xcolor}
\usepackage{breakcites}
\usepackage{lineno}
\usepackage{hyphenat}





\PassOptionsToPackage{hyphens}{url}
\usepackage[colorlinks = true,
            linkcolor = blue,
            urlcolor  = blue,
            citecolor = blue,
            anchorcolor = blue]{hyperref}
\usepackage{etoolbox}
\makeatletter
\patchcmd\@combinedblfloats{\box\@outputbox}{\unvbox\@outputbox}{}{%
  \errmessage{\noexpand\@combinedblfloats could not be patched}%
}%
\makeatother


\usepackage{natbib}




\renewenvironment{abstract}
  {{\bfseries\noindent{\abstractname}\par\nobreak}\footnotesize}
  {\bigskip}

\titlespacing{\section}{0pt}{*3}{*1}
\titlespacing{\subsection}{0pt}{*2}{*0.5}
\titlespacing{\subsubsection}{0pt}{*1.5}{0pt}


\usepackage{authblk}


\usepackage{graphicx}
\usepackage[space]{grffile}
\usepackage{latexsym}
\usepackage{textcomp}
\usepackage{longtable}
\usepackage{tabulary}
\usepackage{booktabs,array,multirow}
\usepackage{amsfonts,amsmath,amssymb}
\providecommand\citet{\cite}
\providecommand\citep{\cite}
\providecommand\citealt{\cite}
% You can conditionalize code for latexml or normal latex using this.
\newif\iflatexml\latexmlfalse
\providecommand{\tightlist}{\setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}%

\AtBeginDocument{\DeclareGraphicsExtensions{.pdf,.PDF,.eps,.EPS,.png,.PNG,.tif,.TIF,.jpg,.JPG,.jpeg,.JPEG}}

\usepackage[utf8]{inputenc}
\usepackage[ngerman,english]{babel}



\usepackage{float}








\begin{document}

\title{Cardiovascular scientific communication: From conferences/clinical to
clinical/conferences}



\author[1]{Chunsong Hu}%
\affil[1]{Nanchang University}%


\vspace{-1em}



  
  \date{June 15, 2024}


\begingroup
\let\center\flushleft
\let\endcenter\endflushleft
\maketitle
\endgroup





\selectlanguage{english}
\begin{abstract}
Good scientific communication is helpful in improvement of
cardiovascular health and life due to a number of scientific highlights
and conducting the outcomes of both basic studies and clinical trials in
cardiovascular disease (CVD). In this article, the author proposed new
concepts of scientific communication from conferences/clinical to
clinical/conferences (Co2Cl \& Cl2Co), discusses related roles in
clinical practice and translational studies as well as scientific
innovation. Since international scientific conferences or congresses
focus on prevention, health promotion, education and training as well as
treatment or management and rehabilitation of CVD, Co2Cl \& Cl2Co are
beneficial to improvement of cardiovascular health and quality of life
due to a number of scientific breakthroughs and a series of discoveries
in cardiovascular medicine. Both models of Co2Cl \& Cl2Co contribute to
better cardiovascular scientific communication, excellent clinical
practice and translational research as well as better scientific
innovation, in particular the pandemic and post-COVID-19 era.%
\end{abstract}%



\sloppy


\textbf{INTRODUCTION}

Since the World Health Organization (WHO) announced the end of the
COVID-19 pandemic, global economic and social development and various
production and life activities have significantly recovered. Although
the epidemic has not completely disappeared, many activities that could
only be carried out online during the pandemic have begun to shift
towards online + offline modes, and even returned to the active offline
mode before the COVID-19 pandemic.

\textbf{CURRENT MAJOR INTERNATIONAL SCIENTIFIC CONFERENCES IN
CARDIOVASCULAR MEDICINE}

Currently, there are a series of academic activities (such as seminars,
forums, and conferences) in the field of biomedicine in the globe, which
include not only life science and basic medicine but also pure clinical
medicine. For example, there are a series of international scientific
conferences or congress in cardiovascular medicine (Table 1) every year
from the American College of Cardiology (ACC), American Heart
Association (AHA), European Society of Cardiology (ESC)/European Society
of Hypertension (ESH), as well as the~China~Heart~Congress (CHC) and
Chinese Society of Cardiology (CSC), the Great Wall
International~Congress~of Cardiology (GW-ICC),\textsuperscript{1} the
Oriental Congress of Cardiology (OCC) and Southern Congress of
Cardiology (SCC). Of course, there are also a lot of international
conferences or congress on special biomedical topics from locals to
nations or regions.\selectlanguage{english}
\begin{figure}[H]
\begin{center}
\includegraphics[width=0.70\columnwidth]{figures/image1/image1}

\end{center}
\end{figure}

\textbf{Figure 1} Scientific communication: From conferences/clinical to
clinical/conferences (C\textsuperscript{o}2C\textsuperscript{l} \&
C\textsuperscript{l}2C\textsuperscript{o}). Since current international
scientific conferences or congresses in the field of cardiovascular
medicine focus on prevention, health promotion, education and training
as well as treatment or management and rehabilitation of cardiovascular
disease (CVD), the new concepts of
C\textsuperscript{o}2C\textsuperscript{l} \&
C\textsuperscript{l}2C\textsuperscript{o} are beneficial to and helpful
in improvement of human cardiovascular health and quality of life due to
conducting the outcomes of both basic studies and clinical trials in CVD
as well as a number of scientific breakthroughs and a series of
discoveries in cardiovascular medicine in the new era. Here, ACC: the
American College of Cardiology; AHA: the American Heart Association;
ESC: the European Society of Cardiology; CHC: the~China~Heart~Congress;
CSC: the Chinese Society of Cardiology; GW-ICC: the Great Wall
International~Congress~of Cardiology; OCC: the Oriental Congress of
Cardiology; SCC: Southern Congress of Cardiology.

\textbf{NEW CONCEPTS OF CARDIOVASCULAR SCIENTIFIC COMMUNICATION: FROM
CONFERENCES/CLINICA TO CLINICAL/CONFERENCES}

Here, the author proposes new concepts of scientific communication: From
conferences/clinical to clinical/conferences, which are referred as to
C\textsuperscript{o}2C\textsuperscript{l} \&
C\textsuperscript{l}2C\textsuperscript{o}. The former is from
conferences to clinical, the latter, of course, is from clinical to
conferences (Figure 1). On the one hand,
C\textsuperscript{o}2C\textsuperscript{l} can enable participating
scholars, researchers, and clinical doctors to more directly and quickly
get the latest information, experience, and results of large-scale
clinical trials from these conferences, and bring these novel knowledge
and information, such as clinical trials
in~heart~failure,\textsuperscript{2} hypertension
guidelines,\textsuperscript{3} expert consensus on
COVID-19,\textsuperscript{4} and interventional
therapeutics\textsuperscript{5} to their clinical and labs or
experimental rooms, thereby accelerating the translation and application
of these academic fruits. On the other hand,
C\textsuperscript{l}2C\textsuperscript{o} can bring in time a lot of
excellent clinical studies or trials and significant discoveries to
famous scientific conferences or forums, and pass the latest research
results and information to international peers, and help carrying out
more and better clinical practices. Herein, both the speakers and the
online and offline audiences may benefit together from these fresh
knowledge and information.

\textbf{CARDIOVASCULAR SCIENTIFIC COMMUNICATION FOR COOPERATION,
INNOVATION AND TRANSLATIONAL APPLICATION}

There are some good recommendations on clinical
studies,\textsuperscript{6} innovation for new treatments and community
health needs multilevel cooperation.\textsuperscript{7-9} In fact, a
series of international~scientific conferences focused on better
innovation and high effective translation application as well as good
cooperation. Herein, the knowledge translation and science communication
are important for public outreach in scientific
exchange.\textsuperscript{10} However, since there aren't enough
effective connectivity, it may hamper optimal fast-track implementation
of translational research findings into health care. Herein, as good
bridges of connectivity, both
C\textsuperscript{o}2C\textsuperscript{l}\&
C\textsuperscript{l}2C\textsuperscript{o} play a crucial role in good
cooperation, better innovation and high effective translational
applications, and in fact, these are also vital goals of scientific
communication (Figure 2), and these may contribute to fast-track
implementation of translational research findings into routine clinical
care.\textsuperscript{11}\selectlanguage{english}
\begin{figure}[H]
\begin{center}
\includegraphics[width=0.70\columnwidth]{figures/image2/image2}

\end{center}
\end{figure}

\textbf{Figure 2} Aims of Scientific Communication. Good cooperation,
better innovation, and high effective translational application are
crucial goals of major international scientific conferences or
congresses. These are also pivotal values of both
C\textsuperscript{o}2C\textsuperscript{l} \&
C\textsuperscript{l}2C\textsuperscript{o}.

A series of studies showed that clinical trials may help to select
programs and agents for CVD and Covid-19. For example, the coronary
artery calcium score had better effect than the polygenic risk score for
risk prediction of coronary heart disease.\textsuperscript{12} Immediate
multivessel percutaneous coronary intervention (PCI) was noninferior to
staged multivessel PCI in hemodynamically stable condition with
ST~elevation~myocardial~infarction and multivessel coronary artery
disease.\textsuperscript{13} Among critically ill cases with COVID-19,
initiation of an ACE inhibitor or ARB did not have substantial more
benefits.\textsuperscript{14} Use of fluvoxamine (twice daily for 10
days) did not improve time to sustained recovery in outpatient case with
mild to moderate COVID-19.\textsuperscript{15} But VV116 was noninferior
to nirmatrelvir-ritonavir for mild-to-moderate
COVID-19.\textsuperscript{16} In addition, a group-based educational
intervention may significantly reduce opioid use for chronic
pain.\textsuperscript{17} Outcome-based and goal-directed financial
incentives were similarly and more effective for weight loss in
low-income populations with obesity.\textsuperscript{18} These fruits
originated from clinical trials may be conducted by both
C\textsuperscript{o}2C\textsuperscript{l} \&
C\textsuperscript{l}2C\textsuperscript{o} models for better
communication among international peers and more applications in
clinical practice. For example, the theme for the Tenth AORTIC
International Conference on Cancer in Africa in Morocco in 2015 was
``Road map to Cancer Control in Africa'',\textsuperscript{19} which
called for application of innovative technologies for combating cancer,
such as new generation sequencing.\textsuperscript{20} International
experts at the 8th AFNET/EHRA consensus conference supported that
implementation of new evidence-based approaches to AF screening and
rhythm management can improve outcomes in patients with
AF.\textsuperscript{21}

\textbf{BOTH C\textsuperscript{o}2C\textsuperscript{l} AND
C\textsuperscript{l}2C\textsuperscript{o} MODELS IMPROVE CARDIOVASCULAR
SCIENTIFIC INNOVASTION}

Indeed, more innovative technologies and discoveries will help to
improve the control and prevention of CVD. For example, innovative
digital health interventions can be an effective strategy to reduce
cardiovascular risk,\textsuperscript{22} clonal hematopoiesis of
indeterminate potential links to an increased risk of CVD due to the
role of inflammasomes,\textsuperscript{23} polygenic risk scores-triaged
coronary artery calcium score for subclinical coronary artery
disease.\textsuperscript{24} In fact, moderate and severe chronic kidney
disease measures may improve CVD risk prediction,\textsuperscript{25}and
CVD events (such as AF, HF, and stroke) strongly and independently
associate with future risk of kidney failure with replacement
therapy.\textsuperscript{26} As a potential means for CVD risk
stratification, artificial intelligence-based ocular image
analysis\textsuperscript{27} contributes to the identification and
prediction of CVD risks and events. Chinese herbal remedies have shown
promise in regulating cardiac ion channels and providing new
opportunities for developing novel anti-arrhythmic
agents,\textsuperscript{28} but more high-quality studies like RCTs are
needed for further clinical application.\textsuperscript{29} However,
all these innovative technologies and discoveries also need to translate
into clinical application by both
C\textsuperscript{o}2C\textsuperscript{l} \&
C\textsuperscript{l}2C\textsuperscript{o} models. And after ethics
approval from the local ethics committees, a series of findings can be
disseminated through scientific meetings and peer-reviewed journals and
via social media.\textsuperscript{22}

\textbf{CONCLUSIONS}

In conclusion, since major international scientific conferences in
cardiovascular medicine mainly focus on basic and clinical studies,
prevention, health promotion, education and training as well as
treatment or management and rehabilitation of CVD, they are beneficial
to and helpful in improvement of human cardiovascular health and quality
of life due to conducting the outcomes of both basic studies and
clinical trials in CVD, a number of scientific highlights and a series
of discoveries in cardiovascular medicine. For example, ``traditional
Chinese medicine Hot Pot''\textsuperscript{30} and single-cell RNA
sequencing\textsuperscript{20} have been novel strategies and new tools
for combating both COVID-19 infection and CVD. In addition,
C\textsuperscript{o}2C\textsuperscript{l} \&
C\textsuperscript{l}2C\textsuperscript{o} have more desirable meanings:
people can see more significant original innovations from scratch
(C\textsuperscript{o}2C\textsuperscript{l}, here, C=see) and from
existence to nothingness (C\textsuperscript{l}2C\textsuperscript{o}),
for example, removing CVD, eliminating diabetes, and eradicating cancer.
Herein, both C\textsuperscript{o}2C\textsuperscript{l} \&
C\textsuperscript{l}2C\textsuperscript{o} contribute to better
scientific communication, excellent clinical practice and translational
studies as well as better scientific innovation, in particular the
COVID-19 pandemic and post-COVID-19 era.

\textbf{Table 1} Major international scientific conferences in
cardiovascular medicine in the globe\selectlanguage{english}
\begin{longtable}[]{@{}llll@{}}
\toprule
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
\textbf{Conference Names}\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
\textbf{Countries or Regions}\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
\textbf{Frequents}\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
\textbf{Web Address}\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
American College of Cardiology (ACC)\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
United States\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
https://accscientificsession.acc.org/en\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
American Heart Association (AHA)\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
United States\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
https://professional.heart.org/en/meetings/scientific-sessions\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
~Asian Pacific Society of Cardiology (APSC) Congress\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Asia-Pacific region\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.apsc2023singapore.com/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Association of Thoracic and Cardiovascular Surgeons of Asia
(ATCSA)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Asia\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
N/A\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Canadian Cardiovascular Congress (CCC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Canada\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://cardiocongress.ca/ or https://ccs.ca/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
China Heart Congress (CHC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
China\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
http://www.chinaheartcongress.com/msite/main/cn\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Cardiovascular and Interventional Radiological Society of Europe
(CIRSE)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.cirse.org/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Cardiometabolic Health Congress (CMHC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
United States\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
N/A\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Cardiovascular Research Technologies (CRT)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
United States\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Forum\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.crtmeeting.org/Default.aspx\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Chinese Society of Cardiology (CSC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
China\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://csc.cma.org.cn/index.html\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
European Atherosclerosis Society (EAS)\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
https://eas-congress.com/2023/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
European Heart Rhythm Association (EHRA)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.escardio.org/Congresses-\&-Events/EHRA-Congress\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
European Society of Cardiology (ESC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.escardio.org/Congresses-Events/ESC-Congress\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
ESC-Association for Acute CardioVascular Care (ACVC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.escardio.org/Sub-specialty-communities/Association-for-Acute-CardioVascular-Care-(ACVC)/Congresses-and-Events\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
ESC-Heart Failure Association (ESC-HFA)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.escardio.org/Congresses-Events/Heart-Failure\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
European Society of Hypertension (ESH)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.eshonline.org/meetingsevents/annual-meeting/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
European Association of Cardiovascular Imaging (EACVI): (EuroEcho)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.cv-imaging.org/echo\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
ESC-European Association for Percutaneous Cardiovascular Interventions
(EuroPCR)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.expobeds.com/event/euro-pcr\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
ESC-Frontiers in CardioVascular Biomedicine (FCVB)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Europe\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.escardio.org/Congresses-Events/Frontiers-in-Cardiovascular-Biomedicine/About-the-congress\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Great Wall International~Congress~of Cardiology (GW-ICC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
China\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
http://www.gw-icc.com/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Heart Failure Society of America\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
United States\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Scientific Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://hfsa.org/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Heart Rhythm Society (HRS)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
United States\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Scientific Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.hrsonline.org/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
International Heart Congress (IHS)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Magnus Group LLC\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://heart.magnusconferences.com/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Japanese Society for Cardiovascular Surgery (JSCVS)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Japan\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
N/A\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Japanese Society for Vascular Surgery (JSVS)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Japan\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Meeting\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.jsvs.org/en/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Northeastern Cardiovascular Forum (NCF)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
China\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
http://www.ncforum.cn/NCF/2023/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Oriental Congress of Cardiology (OCC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
China\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://www.occmd.org/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
\subsection*{Society for Cardiovascular Angiography \& Interventions
(SCAI)}

{\label{society-for-cardiovascular-angiography-interventions-scai}}\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
United States\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
Annual Congress\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
https://scai.org/education-and-events/events-schedule/socime-annual-congress-joint-scai-sessions\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
South China International Congress of Cardiology (SCC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
China\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
http://www.sc-icc.com\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Transcatheter Cardiovascular Therapeutics (TCT)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
United States\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual Global Forum\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
https://tct2023.crfconnect.com/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
TCTAP CardioVasucular Research Foundation (CVRF) \& Heart Institute of
Asian Medical Center\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
Asia-Pacific region (Seoul, Korea)\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.24\columnwidth}\raggedright\strut
https://summit-tctap.com/2024/\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
World Cardiology Congress (WCC)\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
World Heart Federation\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
Annual\strut
\end{minipage} & \begin{minipage}[t]{0.22\columnwidth}\raggedright\strut
www.worldcardiocongress.org\strut
\end{minipage}\tabularnewline
\bottomrule
\end{longtable}

\textbf{Acknowledgments}

The reviewers and editors are gratefully acknowledged for critical
review.

\textbf{Contributors} Concept and design: CH. Acquisition, analysis, or
interpretation of data: CH. Drafting of the manuscript: CH. Critical
revision of the manuscript for important intellectual content: CH.
Administrative, technical, or material support: CH. The author had full
access to all of the data in the study and takes responsibility for the
integrity of the data and the accuracy of the data analysis.

\textbf{Funding} No funding for this study was received.

\textbf{Competing interests} None declared.

\textbf{Patient consent for publication} Not applicable.

\textbf{Ethical approval} Not applicable.

\textbf{Provenance and peer review} Not commissioned; externally peer
reviewed.

\textbf{Data availability statement} Data are available upon reasonable
request.

\textbf{ORCID iD}

Chunsong Hu http://orcid.org/0000-0002-0590-3909

\textbf{REFERENCES}

1. Cao F, Guo N, Yuan Z. Reports from the 2021 Great Wall International
Congress of Cardiology in China. Eur Heart J 2021:ehab852.

2. Anker SD, Butler J, Khan MS, et al. Conducting clinical trials in
heart failure during (and after) the COVID-19 pandemic: an Expert
Consensus Position Paper from the Heart Failure Association (HFA) of the
European Society of Cardiology (ESC). Eur Heart J 2020;41:2109-17.

3. Bakris G, Ali W, Parati G. ACC/AHA Versus ESC/ESH on Hypertension
Guidelines: JACC Guideline Comparison. J Am Coll Cardiol
2019;73:3018-26.

4. Han Y, Zeng H, Jiang H, et al. CSC Expert Consensus on Principles of
Clinical Management of Patients With Severe Emergent Cardiovascular
Diseases During the COVID-19 Epidemic. Circulation 2020;141:e810-6.

5. Gao R. CIT 2018: A New Era, New Journey: Report from the China
Interventional Therapeutics (CIT) 2018, the largest interventional
cardiology scientific congress in the Asia-Pacific region. Eur Heart J
2018;39:2515-7.

6. Hohenschurz-Schmidt D,~Vase L,~Scott W, et al. Recommendations for
the development, implementation, and reporting of control interventions
in efficacy and mechanistic trials of physical, psychological, and
self-management therapies: the CoPPS Statement. BMJ 2023;381:e072108.

7. Gheorghiade M, Larson CJ, Shah SJ, et al. Developing New Treatments
for Heart Failure: Focus on the Heart. Circ Heart Fail 2016;9:e002727.

8. Cottler LB, Nagarajan R. Real-time assessment of community health
needs and concerns. Sci Transl Med 2012;4:119mr2.

9. Anderson JE, Aase K, Bal R, et al. Multilevel influences on resilient
healthcare in six countries: an international comparative study
protocol. BMJ Open 2020;10:e039158.

10. Holmes C, McDonald F, Jones M, Graham J. Knowledge Translation:
Moving Proteomics Science to Innovation in Society. OMICS
2016;20:352-61.

11. Ortmann O, Torode J, Harrison C, Bruns J, Helbig U; Participants of
the ERTM. Research driving~innovation: what are key factors for
successful integration of~translational~science~into oncology care
concepts? 5th European Roundtable Meeting (ERTM) May 4th, 2018, Berlin,
Germany. J Cancer Res Clin Oncol 2019;145:1521-5.

12. Khan SS, Post WS, Guo X, et al. Coronary Artery Calcium Score and
Polygenic Risk Score for the Prediction of Coronary Heart Disease
Events. JAMA 2023;329:1768-77.

13. St\selectlanguage{ngerman}ähli BE, Varbella F, Linke A, et al. MULTISTARS AMI Investigators.
Timing of Complete Revascularization with Multivessel PCI for Myocardial
Infarction. N Engl J Med 2023;389:1368-79.

14. Writing Committee for the REMAP-CAP Investigators; Lawler PR, Derde
LPG, van de Veerdonk FL, et al. Effect of Angiotensin-Converting Enzyme
Inhibitor and Angiotensin Receptor Blocker Initiation on Organ
Support-Free Days in Patients Hospitalized With COVID-19: A Randomized
Clinical Trial. JAMA 2023;329:1183-96.

15. McCarthy MW, Naggie S, Boulware DR, et al. Accelerating COVID-19
Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and
Investigators. Effect of Fluvoxamine vs Placebo on Time to Sustained
Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized
Clinical Trial. JAMA 2023;329:296-305.

16. Cao Z, Gao W, Bao H, et al. VV116 versus Nirmatrelvir-Ritonavir for
Oral Treatment of Covid-19. N Engl J Med 2023;388:406-17.

17. Sandhu HK, Booth K, Furlan AD, et al. Reducing Opioid Use for
Chronic Pain With a Group-Based Intervention: A Randomized Clinical
Trial. JAMA 2023;329:1745-56.

18. Ladapo JA, Orstad SL, Wali S, et al. Effectiveness of Goal-Directed
and Outcome-Based Financial Incentives for Weight Loss in Primary Care
Patients With Obesity Living in Socioeconomically Disadvantaged
Neighborhoods: A Randomized Clinical Trial. JAMA Intern Med
2023;183:61-9.

19. Simbiri KO, Williams CK, Macaluso M, Giordano A. Promoting Cancer
Control in Africa With ''Ubuntu'': A Report of the African Organization
for Research and Training in Africa (AORTIC) 10th Conference, 2015 in
Marrakech, Morocco. J Cell Physiol 2017;232:2287-95.

20. Hu C. A new ``single'' era of biomedicine and implications in
disease research. J Bio-X Res 2023;6:37-48.

21. Schnabel RB, Marinelli EA, Arbelo E, et al. Early diagnosis and
better rhythm management to improve outcomes in patients with atrial
fibrillation: the 8th AFNET/EHRA consensus conference. Europace
2023;25:6-27.

22. Baldassarre D, Iacoviello L, Baetta R, et al. CV-PREVITAL Study
Group. Rationale and design of the CV-PREVITAL study: an Italian
multiple cohort randomised controlled trial
investigating~innovative~digital strategies in primary cardiovascular
prevention. BMJ Open 2023;13:e072040.

23. Yu Z, Fidler TP, Ruan Y, et al. Genetic modification of
inflammation- and clonal hematopoiesis-associated cardiovascular risk. J
Clin Invest 2023;133:e168597.

24. Gray MP, Berman Y, Bottà G, et al. PPP-CAD Collaborators.
Incorporating a polygenic risk score-triaged coronary calcium score into
cardiovascular disease examinations to identify subclinical coronary
artery disease (ESCALATE): Protocol for a prospective, nonrandomized
implementation trial. Am Heart J 2023;264:163-73.

25. Matsushita K, Kaptoge S, Hageman SHJ, et al. Including measures of
chronic kidney disease to improve cardiovascular risk prediction by
SCORE2 and SCORE2-OP. Eur J Prev Cardiol 2023;30:8-16.

26. Mark PB, Carrero JJ, Matsushita K, et al. Major cardiovascular
events and subsequent risk of kidney failure with replacement therapy: a
CKD Prognosis Consortium study. Eur Heart J 2023;44:1157-66.

27. Huang Y, Cheung CY, Li D, et al. AI-integrated ocular imaging for
predicting cardiovascular disease: advancements and future outlook. Eye
(Lond) 2023; Sep 14. doi: 10.1038/s41433-023-02724-4.

28. Yan Z, Zhong L, Zhu W, Chung SK, Hou P. Chinese herbal medicine for
the treatment of cardiovascular diseases \selectlanguage{english}- Targeting cardiac ion
channels. Pharmacol Res 2023;192:106765.

29. Li C, Wang C, Hao J, et al. Level of evidence supporting the Chinese
cardiovascular disease clinical practice guidelines and its evolution in
the past two decades. Lancet Reg Health West Pac 2023;36:100773.

30. Hu C. Emergency Protective Measures and Strategies of Covid-19: From
Lifestyle to Traditional Chinese Medicine. Clin Complement Med Pharmacol
2023;3:100089.

\selectlanguage{english}
\FloatBarrier
\end{document}

